Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 1 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Leukoplakia, Oral 1Klatskin Tumor 1Keratosis, Actinic 1Healthy Volunteer 1Bile Duct Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Photosensitizing Agents × Clear all
NCT07453472 2026-03-06

PDT CALCI HOL

All India Institute of Medical Sciences

Phase 3 Not yet recruiting
166 enrolled
Head & Neck

Leukoplakia, Oral

NCT05551299 2025-03-27

CARP

University of Leipzig

Phase 4 Recruiting
258 enrolled
Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

NCT00756288 2021-12-06

Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses

Northwestern University

Phase NA Withdrawn
Dermatologic

Keratosis, Actinic

NCT02947854 2019-08-28

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

PCI Biotech AS

Phase 1 Completed
96 enrolled

Healthy Volunteer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡